Periolimel N4E, Emulsion for Infusion

Manufacturer
BAXTER S.A,
 
Contents
PeriOlimel N4E Per 1,500 mL Refined olive oil + refined soya bean oil 45 g, alanine 5.5 g, arginine 3.72 g, aspartic acid 1.1 g, glutamic acid 1.9 g, glycine 2.63 g, histidine 2.26 g, isoleucine 1.9 g, leucine 2.63 g, lysine 2.99 g (lysine acetate 4.21 g), methionine 1.9 g, phenylalanine 2.63 g, proline 2.26 g, serine 1.5 g, threonine 1.9 g, tryptophan 0.64 g, tyrosine 0.1 g, valine 2.43 g, Na acetate trihydrate 1.73 g, hydrated Na glycerophosphate 2.87 g, KCl 1.79 g, Mg chloride hexahydrate 0.67 g, Ca chloride dihydrate 0.44 g, glucose anhydrous 112.5 g (glucose monohydrate 123.75 g). Per 2,000 mL Refined olive oil + refined soya bean oil 60 g, alanine 7.33 g, arginine 4.96 g, aspartic acid 1.46 g, glutamic acid 2.53 g, glycine 3.51 g, histidine 3.02 g, isoleucine 2.53 g, leucine 3.51 g, lysine 3.98 g (lysine acetate 5.62 g), methionine 2.53 g, phenylalanine 3.51 g, proline 3.02 g, serine 2 g, threonine 2.53 g, tryptophan 0.85 g, tyrosine 0.13 g, valine 3.24 g, Na acetate trihydrate 2.31 g, hydrated Na glycerophosphate 3.82 g, KCl 2.38 g, Mg chloride hexahydrate 0.9 g, Ca chloride dihydrate 0.59 g, glucose anhydrous 150 g (glucose monohydrate 165 g)
 
Indication
Parenteral nutrition for adults & childn >2 yr when oral or enteral nutrition is impossible, insufficient or contraindicated.
 
Instruction
Administered through a peripheral or central vein.
 
Drug interaction
Possibility of pseudoagglutination when administered simultaneously w/ blood through the same infusion tubing. Precipitation of ceftriaxone-Ca can occur when ceftriaxone is mixed w/ Ca-containing soln in the same IV administration line. Risk of hyperkalaemia w/ K-sparing diuretics (eg, amiloride, spironolactone, triamterene), ACE inhibitors, AIIA, tacrolimus or cyclosporine.